Cc1ccc(S(=O)(=O)N/N=C(\c2nc3ccc(Cl)cc3[nH]c2=O)C(O)c2ccco2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?